Prognostic Significance of First Week NT-ProBNP Levels in Heart Failure
Introduction: Clinical history, signs and symptoms along with non-invasive imaging help in diagnosis and management of Heart Failure (HF). Limited data exists in evaluating the role of cardiac biomarkers in diagnostic and prognostic work up in cases with clinical evidence of HF in an Indian setup. A...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
JCDR Research and Publications Private Limited
2018-09-01
|
| Series: | Journal of Clinical and Diagnostic Research |
| Subjects: | |
| Online Access: | https://jcdr.net/articles/PDF/12009/35533_CE[Ra]_F(Sh)_PF1(AGAK)_PFA(AK)_PB(AG_SS)_PN(SS).pdf |
| _version_ | 1819289841825742848 |
|---|---|
| author | SHOBHITENDU KABI SIBA PRASAD DALAI KAMAL KANT JENA AKSHAYA KUMAR SAMAL BAIKUNTHA NATH PANDA SRIKANT KUMAR DHAR |
| author_facet | SHOBHITENDU KABI SIBA PRASAD DALAI KAMAL KANT JENA AKSHAYA KUMAR SAMAL BAIKUNTHA NATH PANDA SRIKANT KUMAR DHAR |
| author_sort | SHOBHITENDU KABI |
| collection | DOAJ |
| description | Introduction: Clinical history, signs and symptoms along with non-invasive imaging help in diagnosis and management of Heart Failure (HF). Limited data exists in evaluating the role of cardiac biomarkers in diagnostic and prognostic work up in cases with clinical evidence of HF in an Indian setup. Aim: The aim was to find out if first week N-Terminal -pro Brain Natriuretic Peptide (NT-proBNP) levels can be used as a prognostic indicator and to correlate with duration of hospital stay and mortality during the course of treatment and followup. Materials and Methods: A hospital based cross-sectional observational study was carried out for a period of two years and 160 patients with clinical evidence of HF according to Framingham’s criteria irrespective of aetiology and ejection fraction were included in the study. NT-proBNP were estimated at admission, at one-week interval and at discharge. NTproBNP levels were correlated with duration of hospital stay and mortality during the course of treatment and follow-up. Results: Patients with Rheumatic Heart Disease (RHD) had the highest mean NT-proBNP levels even with higher ejection fractions. Mean NT-proBNP levels in patients with Cor-pulmonale were significantly lower (3634.8 pg/dL) than patients of HF with non-pulmonary cause (8418 pg/dL). Patients with NT-proBNP levels more than 15,000 pg/dL invariably stayed for more than two weeks. The decline of NT-proBNP levels more than 90% of the initial values in one week follow up were prognostic marker for recovery (p<0.01). Patients who had admission NT-proBNP levels of more than 10,000 pg/dL, and those cases with fall of NT-proBNP levels less than 50% after one week of therapy had increased duration of hospital stay and or higher risk of mortality. Conclusion: First week NT-proBNP can be used routinely in monitoring the response to therapy, prognosticate the duration of hospital stay, outcome in HF. |
| first_indexed | 2024-12-24T03:13:16Z |
| format | Article |
| id | doaj.art-b69134354971450ea5acb2e4ebd65aac |
| institution | Directory Open Access Journal |
| issn | 2249-782X 0973-709X |
| language | English |
| last_indexed | 2024-12-24T03:13:16Z |
| publishDate | 2018-09-01 |
| publisher | JCDR Research and Publications Private Limited |
| record_format | Article |
| series | Journal of Clinical and Diagnostic Research |
| spelling | doaj.art-b69134354971450ea5acb2e4ebd65aac2022-12-21T17:17:44ZengJCDR Research and Publications Private LimitedJournal of Clinical and Diagnostic Research2249-782X0973-709X2018-09-01129OC14OC1710.7860/JCDR/2018/35533.12009Prognostic Significance of First Week NT-ProBNP Levels in Heart FailureSHOBHITENDU KABI0SIBA PRASAD DALAI1KAMAL KANT JENA2AKSHAYA KUMAR SAMAL3BAIKUNTHA NATH PANDA4SRIKANT KUMAR DHAR5Associate Professor, Department of Medicine, Ims and SUM Hospital, Bhubaneswar, Odisha, India.Senior Resident, Department of Medicine, Ims and SUM Hospital, Bhubaneswar, Odisha, India.Junior Resident, Department of Medicine, Ims and SUM Hospital, Bhubaneswar, Odisha, India.Professor, Department of Cardiology, Ims and SUM Hospital, Bhubaneswar, Odisha, India.Professor, Department of Medicine, Ims and SUM Hospital, Bhubaneswar, Odisha, India.Associate Professor, Department of Medicine, Ims and SUM Hospital, Bhubaneswar, Odisha, India.Introduction: Clinical history, signs and symptoms along with non-invasive imaging help in diagnosis and management of Heart Failure (HF). Limited data exists in evaluating the role of cardiac biomarkers in diagnostic and prognostic work up in cases with clinical evidence of HF in an Indian setup. Aim: The aim was to find out if first week N-Terminal -pro Brain Natriuretic Peptide (NT-proBNP) levels can be used as a prognostic indicator and to correlate with duration of hospital stay and mortality during the course of treatment and followup. Materials and Methods: A hospital based cross-sectional observational study was carried out for a period of two years and 160 patients with clinical evidence of HF according to Framingham’s criteria irrespective of aetiology and ejection fraction were included in the study. NT-proBNP were estimated at admission, at one-week interval and at discharge. NTproBNP levels were correlated with duration of hospital stay and mortality during the course of treatment and follow-up. Results: Patients with Rheumatic Heart Disease (RHD) had the highest mean NT-proBNP levels even with higher ejection fractions. Mean NT-proBNP levels in patients with Cor-pulmonale were significantly lower (3634.8 pg/dL) than patients of HF with non-pulmonary cause (8418 pg/dL). Patients with NT-proBNP levels more than 15,000 pg/dL invariably stayed for more than two weeks. The decline of NT-proBNP levels more than 90% of the initial values in one week follow up were prognostic marker for recovery (p<0.01). Patients who had admission NT-proBNP levels of more than 10,000 pg/dL, and those cases with fall of NT-proBNP levels less than 50% after one week of therapy had increased duration of hospital stay and or higher risk of mortality. Conclusion: First week NT-proBNP can be used routinely in monitoring the response to therapy, prognosticate the duration of hospital stay, outcome in HF.https://jcdr.net/articles/PDF/12009/35533_CE[Ra]_F(Sh)_PF1(AGAK)_PFA(AK)_PB(AG_SS)_PN(SS).pdfbiomarkershospital staymortalitynon-invasive markers |
| spellingShingle | SHOBHITENDU KABI SIBA PRASAD DALAI KAMAL KANT JENA AKSHAYA KUMAR SAMAL BAIKUNTHA NATH PANDA SRIKANT KUMAR DHAR Prognostic Significance of First Week NT-ProBNP Levels in Heart Failure Journal of Clinical and Diagnostic Research biomarkers hospital stay mortality non-invasive markers |
| title | Prognostic Significance of First Week NT-ProBNP Levels in Heart Failure |
| title_full | Prognostic Significance of First Week NT-ProBNP Levels in Heart Failure |
| title_fullStr | Prognostic Significance of First Week NT-ProBNP Levels in Heart Failure |
| title_full_unstemmed | Prognostic Significance of First Week NT-ProBNP Levels in Heart Failure |
| title_short | Prognostic Significance of First Week NT-ProBNP Levels in Heart Failure |
| title_sort | prognostic significance of first week nt probnp levels in heart failure |
| topic | biomarkers hospital stay mortality non-invasive markers |
| url | https://jcdr.net/articles/PDF/12009/35533_CE[Ra]_F(Sh)_PF1(AGAK)_PFA(AK)_PB(AG_SS)_PN(SS).pdf |
| work_keys_str_mv | AT shobhitendukabi prognosticsignificanceoffirstweekntprobnplevelsinheartfailure AT sibaprasaddalai prognosticsignificanceoffirstweekntprobnplevelsinheartfailure AT kamalkantjena prognosticsignificanceoffirstweekntprobnplevelsinheartfailure AT akshayakumarsamal prognosticsignificanceoffirstweekntprobnplevelsinheartfailure AT baikunthanathpanda prognosticsignificanceoffirstweekntprobnplevelsinheartfailure AT srikantkumardhar prognosticsignificanceoffirstweekntprobnplevelsinheartfailure |